VENUS MEDTECH-B(02500),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02500 VENUS MEDTECH-B

Market Closed 01-23 16:08:26

3.100

+0.120

+4.03%

High3.200	Low3.040	Vol1.88M
Open3.120	D1 Closing2.980	Amplitude5.37%
Mkt Cap1.37B	Tradable Cap1.37B	Total Shares441.01M
T/O5.85M	T/O Rate0.43%	Tradable Shares441.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02500","market":"HK","secType":"STK","nameCN":"VENUS MEDTECH-B","latestPrice":3.1,"timestamp":1769155706849,"preClose":2.98,"halted":0,"volume":1882000,"delay":0,"changeRate":0.040268456375838965,"floatShares":441010235,"shares":441011443,"eps":-1.631219,"marketStatus":"Market Closed","change":0.12,"latestTime":"01-23 16:08:26","open":3.12,"high":3.2,"low":3.04,"amount":5849455,"amplitude":0.053691,"askPrice":3.13,"askSize":20000,"bidPrice":3.1,"bidSize":28000,"shortable":0,"etf":0,"ttmEps":-1.608,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769391000000},"marketStatusCode":7,"adr":0,"listingDate":1575907200000,"exchange":"SEHK","adjPreClose":2.98,"openAndCloseTimeList":[[1769131800000,1769140800000],[1769144400000,1769155200000]],"volumeRatio":0.372663,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02500/tweets","defaultTab":"tweets","newsList":[{"id":"2605044456","title":"Even With A 26% Surge, Cautious Investors Are Not Rewarding Venus Medtech (Hangzhou) Inc.'s (HKG:2500) Performance Completely","url":"https://stock-news.laohu8.com/highlight/detail?id=2605044456","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605044456?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:42","pubTimestamp":1769121737,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. ( HKG:2500 ) shares have had a really impressive month, gaining 26% after a shaky period...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/even-with-a-26-surge-cautious-investors-are-not-rewarding-ve-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/even-with-a-26-surge-cautious-investors-are-not-rewarding-ve-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","02500","BK1100","BK4211","ISBC","BK1574"],"gpt_icon":0},{"id":"1172369033","title":"VENUS MEDTECH-B (02500): Cardiovalve Ltd. and MTH IP, L.P. File Patent Infringement Lawsuit Against Edwards in the U.S. Over Patent No. 385","url":"https://stock-news.laohu8.com/highlight/detail?id=1172369033","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172369033?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:20","pubTimestamp":1769055640,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) announced that on June 9, 2025, the United States Court of Appeals for the Federal Circuit issued a ruling affirming the validity of certain claims within U.S. Patent No....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU1481599808.USD","BK4088","LU2463526074.USD","LU1481600234.SGD","LU1169590202.USD","IP","02500","91348","BK4585","BK4136","IE00B3T34201.USD","BK1100","LU1487256676.USD","MTH","BK4588","LU1169589451.USD","BK1574"],"gpt_icon":0},{"id":"1126243874","title":"Venus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware","url":"https://stock-news.laohu8.com/highlight/detail?id=1126243874","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126243874?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:02","pubTimestamp":1769054557,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"gpt_icon":0},{"id":"2605599824","title":"Venus MedTech Faces Patent Infringement Lawsuit Over Heart Valve Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2605599824","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605599824?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:01","pubTimestamp":1769054485,"startTime":"0","endTime":"0","summary":"Venus MedTech Hangzhou Inc. has provided an update regarding ongoing patent litigation in the United States. On January 14, 2026, Cardiovalve Ltd. and MTH IP, L.P. filed a patent infringement lawsuit against Edwards Lifesciences in the United States District Court for the District of Delaware. The case concerns the alleged infringement of the US patent 10,702,385, which covers an implant for heart valves and is owned by Cardiovalve Ltd. The lawsuit follows a June 2025 decision by the US Court of Appeals for the Federal Circuit affirming the patentability of certain claims of this patent, after they were challenged by Edwards Lifesciences in an inter partes review. Venus MedTech has advised its shareholders and potential investors to exercise caution in dealings related to its shares while the litigation is ongoing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL7wcT4n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","02500","BK4585","LU0345774631.USD","BK4082","IE00BFXG0V08.USD","SG9999001176.USD","EW","IE00BN0W2V16.EUR","BK1583","LU0345774391.USD","SG9999001176.SGD","IE00BN0W2T93.GBP","SG9999013999.USD","IE00BN0W2W23.USD","IE00BYQQ9H92.USD","BK4567","BK4504","BK1100","BK4588","BK1574"],"gpt_icon":0},{"id":"2604191937","title":"BRIEF-Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191937","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191937?lang=en_us&edition=fundamental","pubTime":"2026-01-20 18:27","pubTimestamp":1768904856,"startTime":"0","endTime":"0","summary":"BRIEF-Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False MarketJan 20  - Venus Medtech Hangzhou 2500.HK:CONFIRMS IT IS NOT AWARE OF ANY INFO WHICH MUST BE ANNOUNCED TO AVOID FALSE MARKET IN CO'S SECURITIESREFERS TO RECENT PRESS ARTICLE IN RELATION TO A PATENT INFRINGEMENT LAWSUIT FILED BY UNIT, OTHERSFurther company coverage: 2500.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK07P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02500","BK1100","BK1583"],"gpt_icon":0},{"id":"2604169444","title":"Venus Medtech Denies Any Undisclosed Information After US Patent Lawsuit Report; Shares Slip 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604169444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604169444?lang=en_us&edition=fundamental","pubTime":"2026-01-20 13:43","pubTimestamp":1768887818,"startTime":"0","endTime":"0","summary":"Venus Medtech  said it is not aware of any undisclosed inside information following media reports about a patent infringement lawsuit involving its U.S. subsidiary, according to a Tuesday Hong Kong bourse filing.The company made the clarification after the Hong Kong Stock Exchange requested a response to a press article on litigation filed by Cardiovalve and MTH IP against Edwards Lifesciences in a U.S. federal court, the filing said.Shares of the firm were down more than 6% in Tuesday afternoon trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["III","BK1100","BK1583","02500","BK1574","BK4134"],"gpt_icon":0},{"id":"2604816562","title":"Venus Medtech Hangzhou - Refers to Recent Press Article in Relation to a Patent Infringement Lawsuit Filed by Unit, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2604816562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604816562?lang=en_us&edition=fundamental","pubTime":"2026-01-20 12:08","pubTimestamp":1768882100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK07P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1100","02500","BK1583"],"gpt_icon":0},{"id":"2604165647","title":"Venus Medtech Hangzhou - Confirms It Is Not Aware of Any Info Which Must Be Announced to Avoid False Market in Co's Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2604165647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604165647?lang=en_us&edition=fundamental","pubTime":"2026-01-20 12:08","pubTimestamp":1768882100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK07P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02500","BK1583","BK1574","BK1100"],"gpt_icon":0},{"id":"1128190795","title":"Hong Kong Stock Movement | VENUS MEDTECH-B (02500) Rises Nearly 8% as Subsidiary Files Patent Infringement Lawsuit in US Against Edwards' Key Product PASCAL","url":"https://stock-news.laohu8.com/highlight/detail?id=1128190795","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128190795?lang=en_us&edition=fundamental","pubTime":"2026-01-19 15:11","pubTimestamp":1768806670,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) saw its intraday surge exceed 14%. As of the time of writing, the stock was up 7.99%, trading at HK$3.65, with a turnover of HK$26.2799 million. On January 14 local time,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02500","BK1100","BK1574"],"gpt_icon":0},{"id":"2603289256","title":"Discover 3 Asian Penny Stocks With Market Caps Larger Than US$100M","url":"https://stock-news.laohu8.com/highlight/detail?id=2603289256","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603289256?lang=en_us&edition=fundamental","pubTime":"2026-01-15 06:02","pubTimestamp":1768428145,"startTime":"0","endTime":"0","summary":"As Asian markets continue to navigate a landscape marked by geopolitical tensions and economic shifts, investors are increasingly exploring diverse opportunities across the region. Penny stocks, often seen as smaller or newer companies with potential for growth, remain an intriguing segment for those seeking untapped value. In this article, we explore three Asian penny stocks that stand out for their financial strength and potential to offer compelling investment opportunities in today's...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/discover-3-asian-penny-stocks-with-market-caps-larger-than-u","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/discover-3-asian-penny-stocks-with-market-caps-larger-than-u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0516423174.USD","02500","LU0516422366.SGD","BK6065","SGXZ43160589.SGD","SGXZ58947870.SGD","SG9999003826.SGD","SG9999016042.SGD","LU1668664300.SGD","LU1242518931.SGD","00028","BK1583","SG9999000475.SGD","LU0516422952.EUR","SG9999014484.SGD","SGXZ27511609.SGD","LU0082770016.USD","BK4585","BK4588","BK6504","LU1861217088.USD","BK4166","BK8040","SG9999000343.SGD","SG9999013486.USD","SG9999014492.USD","LU1861220207.SGD","SG9999013460.SGD","LU2360107671.USD","SGXZ24219693.SGD","BK1574","LU0082770016.SGD","LU0516422440.USD","LU0164939612.USD","BK1100","06100","LU0620787316.HKD","LU1242518857.USD","LU1791807156.HKD","SG9999013478.USD","SG9999002679.SGD","LU0979878070.USD","LU0106831901.USD","SG9999004360.SGD","BK8065","BK8052","LU0516423091.SGD"],"gpt_icon":0},{"id":"2595733398","title":"BRIEF-Venus Medtech Hangzhou To Sell 157,800 Series B Preferred Shares Of Valgen Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2595733398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595733398?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:47","pubTimestamp":1767016031,"startTime":"0","endTime":"0","summary":"BRIEF-Venus Medtech Hangzhou To Sell 157,800 Series B Preferred Shares Of Valgen HoldingDec 29 (Reuters) - Venus Medtech Hangzhou 2500.HK:UNIT TO SELL 157,800 SERIES B PREFERRED SHARES OF VALGEN HOLDING FOR US$15 MILLIONFurther company coverage: 2500.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XZ00M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","02500","BK1574"],"gpt_icon":0},{"id":"1143559494","title":"VENUS MEDTECH-B (02500) to Sell Approximately 1.05% Stake in Valgen Holding Corporation for $15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1143559494","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143559494?lang=en_us&edition=fundamental","pubTime":"2025-12-29 20:44","pubTimestamp":1767012261,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) has announced that on December 29, 2025, the seller, Venus Medtech (Hong Kong) Limited, entered into a share transfer agreement with the buyer, Broncus China Holding...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02500","BK1574","BK1100"],"gpt_icon":0},{"id":"2595084787","title":"Venus Medtech Hangzhou - Unit to Sell 157,800 Series B Preferred Shares of Valgen Holding for US$15 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2595084787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595084787?lang=en_us&edition=fundamental","pubTime":"2025-12-29 20:35","pubTimestamp":1767011719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XZ00M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02500","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"1149691374","title":"VENUS MEDTECH-B (02500) Rises Over 4% as Tricuspid Valve Replacement Product Cardiovalve Submits EU CE Mark Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1149691374","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149691374?lang=en_us&edition=fundamental","pubTime":"2025-12-24 10:40","pubTimestamp":1766544014,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) surged over 4%, reaching HK$2.48 by the time of writing, with a trading volume of HK$1.1562 million. The company announced that it has formally submitted the complete...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CE","FSXEmain","BK4585","BK1574","02500","FESXmain","BK4588","BK4109","BK1100","BK1583"],"gpt_icon":0},{"id":"2593442725","title":"Venus Medtech Seeks EU Approval for Cardiovalve System","url":"https://stock-news.laohu8.com/highlight/detail?id=2593442725","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593442725?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:24","pubTimestamp":1766539451,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) (HKG:2500) said it filed for EU regulatory approval to begin selling its Cardiovalve system in the region, according to a Hong Kong bourse filing Wednesday.The product is designed to treat both mitral regurgitation and tricuspid regurgitation in the heart.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02500","BK1583","BK1100","BK4156","BK1574"],"gpt_icon":0},{"id":"1156767735","title":"VENUS MEDTECH-B (02500) Submits CE MDR Certification Application for Cardiovalve Transcatheter Tricuspid Valve Replacement System","url":"https://stock-news.laohu8.com/highlight/detail?id=1156767735","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156767735?lang=en_us&edition=fundamental","pubTime":"2025-12-24 07:16","pubTimestamp":1766531796,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) announced that the group has recently submitted the complete application for CE MDR certification of its Cardiovalve transcatheter tricuspid valve replacement system...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK4109","02500","CE","BK4585","BK4588","BK1100"],"gpt_icon":0},{"id":"2593015446","title":"Venus MedTech Submits CE MDR Application for Cardiovalve Tricuspid Valve Replacement","url":"https://stock-news.laohu8.com/highlight/detail?id=2593015446","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593015446?lang=en_us&edition=fundamental","pubTime":"2025-12-24 07:06","pubTimestamp":1766531186,"startTime":"0","endTime":"0","summary":"Venus MedTech  Inc. has announced the formal submission of all application materials for CE MDR marking to a European Notified Body for its Cardiovalve transcatheter tricuspid valve replacement system. This voluntary announcement updates shareholders and potential investors on the latest business development and product research progress. The Cardiovalve System is designed to treat both mitral and tricuspid regurgitation, featuring a transfemoral approach and a large annulus design suitable for approximately 95% of patients. The company cautioned that there is no guarantee of eventual marketing approval for the product. No grant or funding from multiple organizations was mentioned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDLb2wybJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02500","BK1574","BK1100"],"gpt_icon":0},{"id":"1137198581","title":"Venus Medtech (02500) Releases Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1137198581","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137198581?lang=en_us&edition=fundamental","pubTime":"2025-12-03 16:54","pubTimestamp":1764752048,"startTime":"0","endTime":"0","summary":"Venus Medtech (Hangzhou) Inc. (02500) announced that, as of November 30, 2025, its total authorised/registered share capital remained at RMB 441,011,443, composed of 441,010,235 H shares and 1,208...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"gpt_icon":0},{"id":"1143735789","title":"Venus Medtech (2500) Announces EGM Poll Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1143735789","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143735789?lang=en_us&edition=fundamental","pubTime":"2025-11-28 18:44","pubTimestamp":1764326698,"startTime":"0","endTime":"0","summary":"On November 28, 2025, Venus Medtech (Hangzhou) Inc. (2500) convened an Extraordinary General Meeting (EGM) at its facility in Hangzhou, the PRC. The total number of issued shares as of the date of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"gpt_icon":0},{"id":"1165386138","title":"Former Heart Valve Leader VENUS MEDTECH-B Faces Cash Crunch and Procurement Policy Squeeze","url":"https://stock-news.laohu8.com/highlight/detail?id=1165386138","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165386138?lang=en_us&edition=fundamental","pubTime":"2025-11-21 17:22","pubTimestamp":1763716927,"startTime":"0","endTime":"0","summary":"Once a high-flying pioneer in China's heart valve market, VENUS MEDTECH-B (02500.HK) is now struggling with severe liquidity pressures. The company recently announced the discounted sale of its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","159399","BK1583","02500"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.venusmedtech.com","stockEarnings":[{"period":"1week","weight":-0.0828},{"period":"1month","weight":0.2551},{"period":"3month","weight":0.2062},{"period":"6month","weight":0.0993},{"period":"1year","weight":-0.4484},{"period":"ytd","weight":0.3025}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":0.036},{"period":"3month","weight":0.0225},{"period":"6month","weight":0.0536},{"period":"1year","weight":0.3578},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Venus Medtech Hangzhou Inc is a China-based company principally engaged in the research and development, and the manufacture and sale of bioprosthetic heart valves. The Company mainly engages in minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company provides interventional heart valve devices for valvular heart disease including aortic valve, pulmonic valve, mitral valve and tricuspid valve, a radio frequency ablation system for interventional treatment of HCM, a renal artery denervation ultrasound ablation system for interventional treatment of hypertension and other accessory consumables. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8/TAV8 and TriGUARD3 Cerebral Embolic Protection Device. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.091994},{"month":2,"riseRate":0.25,"avgChangeRate":-0.081628},{"month":3,"riseRate":0,"avgChangeRate":-0.239969},{"month":4,"riseRate":0.8,"avgChangeRate":0.067278},{"month":5,"riseRate":0.2,"avgChangeRate":-0.086923},{"month":6,"riseRate":0.6,"avgChangeRate":0.114518},{"month":7,"riseRate":0.4,"avgChangeRate":0.007533},{"month":8,"riseRate":0.2,"avgChangeRate":-0.115597},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03911},{"month":10,"riseRate":0.2,"avgChangeRate":-0.074139},{"month":11,"riseRate":0.6,"avgChangeRate":0.100743},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006043}],"exchange":"SEHK","name":"VENUS MEDTECH-B","nameEN":"VENUS MEDTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VENUS MEDTECH-B(02500),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VENUS MEDTECH-B(02500) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VENUS MEDTECH-B,02500,VENUS MEDTECH-B股票,VENUS MEDTECH-B股票老虎,VENUS MEDTECH-B股票老虎国际,VENUS MEDTECH-B行情,VENUS MEDTECH-B股票行情,VENUS MEDTECH-B股价,VENUS MEDTECH-B股市,VENUS MEDTECH-B股票价格,VENUS MEDTECH-B股票交易,VENUS MEDTECH-B股票购买,VENUS MEDTECH-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VENUS MEDTECH-B(02500),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VENUS MEDTECH-B(02500) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}